BCM
Bayesian Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,800
| Closed | -$413K | – | 740 |
|
|
2024
Q3 | $413K | Buy |
8,800
+2,600
| +42% | +$122K | 0.05% | 415 |
|
|
2024
Q2 | $335K | Sell |
6,200
-34,800
| -85% | -$1.88M | 0.04% | 481 |
|
|
2024
Q1 | $2.79M | Buy |
+41,000
| New | +$2.79M | 0.27% | 97 |
|
|
2023
Q3 | – | Sell |
-18,129
| Closed | -$1.02M | – | 746 |
|
|
2023
Q2 | $1.02M | Buy |
+18,129
| New | +$1.02M | 0.11% | 254 |
|
|
2023
Q1 | – | Sell |
-12,792
| Closed | -$520K | – | 848 |
|
|
2022
Q4 | $520K | Buy |
+12,792
| New | +$520K | 0.08% | 350 |
|
|
2022
Q2 | – | Sell |
-5,000
| Closed | -$314K | – | 833 |
|
|
2022
Q1 | $314K | Buy |
+5,000
| New | +$314K | 0.05% | 506 |
|
|
2020
Q2 | – | Sell |
-6,200
| Closed | -$263K | – | 567 |
|
|
2020
Q1 | $263K | Buy |
+6,200
| New | +$263K | 0.06% | 504 |
|
|
2019
Q3 | – | Sell |
-4,594
| Closed | -$216K | – | 544 |
|
|
2019
Q2 | $216K | Sell |
4,594
-4,906
| -52% | -$231K | 0.04% | 425 |
|
|
2019
Q1 | $339K | Buy |
+9,500
| New | +$339K | 0.07% | 366 |
|